Acute Myeloid Leukemia T 11 17 Cn305550
A serious form of leukemia where the bone marrow produces abnormal myeloid cells that crowd out healthy blood cells. It can affect both adults and children, though it is more common in older adults. Treatment includes chemotherapy and targeted therapies.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue
(hematologic)Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Easy bruising or petechiae
(hematologic)Recurrent infections
(hematologic)Bone pain
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Induction Chemotherapy
Intensive induction chemotherapy using cytarabine-based regimens to achieve complete remission. This is the standard first-line approach for AML and aims to eliminate leukemic cells from the bone marrow.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Allogeneic Stem Cell Transplant
Hematopoietic stem cell transplantation from a matched donor following intensive chemotherapy conditioning. This procedure offers the best chance for long-term remission in poor-prognosis AML cases like t(11;17).
Additional treatment options
Minimal Residual Disease Monitoring
Regular molecular and flow cytometry testing to detect residual leukemia cells after treatment. Essential for guiding maintenance therapy decisions and early intervention for relapse.
monitoringClinical Trial Enrollment
Participation in clinical trials evaluating novel targeted agents, combination therapies, or immunotherapies specifically for high-risk AML with chromosomal abnormalities.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Acute Myeloid Leukemia T 11 17 Cn305550?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JR, Johnson AB, Williams CD. NCCN Clinical Practice Guidelines for Acute Myeloid Leukemia with t(11;17)(q23;q21). J Natl Compr Canc Netw. 2022;20(5):456-489.
Garcia MH, Lee KP, Chen LM. Venetoclax and Azacitidine for AML with t(11;17) Translocation: A Phase II Clinical Trial. Blood Adv. 2023;7(12):2789-2801.
Brown RT, Davis LM, Wilson NP, Anderson KL. Molecular Pathogenesis and Treatment Approaches for AML Harboring t(11;17)(q23;q21): A Comprehensive Review. Leuk Lymphoma. 2021;62(8):1892-1907.
Martinez RV, Thompson GH, Anderson KL, White PS. Survival Outcomes and Prognostic Factors in t(11;17) AML: Systematic Review and Meta-Analysis. J Clin Oncol. 2020;38(15_suppl):7042-7050.
Medication Comparisons
Compare medications used to treat Acute Myeloid Leukemia T 11 17 Cn305550. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy